0
13
Journal Articles about Antipsychotics Showing 101-120 of 931
Article | September 01, 2004
Equivalent Occupancy of Dopamine D1 and D2 Receptors With Clozapine: Differentiation From Other Atypical Antipsychotics
Johannes Tauscher, M.D.; Tabasum Hussain, Ph.D.; Ofer Agid, M.D.; N. Paul L.G. Verhoeff, M.D., Ph.D.; Alan A. Wilson, Ph.D.; Sylvain Houle, M.D., Ph.D.; Gary Remington, M.D., Ph.D.; Robert B. Zipursky, M.D.; Shitij Kapur, M.D., Ph.D.
The American Journal of Psychiatry. 2004 September ; 9(161):1620-1625
PDFPDF
Brief Report | September 01, 2004
Incidence of Newly Diagnosed Diabetes Attributable to Atypical Antipsychotic Medications
Douglas L. Leslie, Ph.D.; Robert A. Rosenheck, M.D.
The American Journal of Psychiatry. 2004 September ; 9(161):1709-1711
PDFPDF
Article | August 01, 2004
Use of Psychotropic Medications Before and After Sept. 11, 2001
Benjamin G. Druss, M.D., M.P.H.; Steven C. Marcus, Ph.D.
The American Journal of Psychiatry. 2004 August ; 8(161):1377-1383
PDFPDF
Reviews and Overviews | August 01, 2004
Gender Differences in the Prescribing of Antipsychotic Drugs
Mary V. Seeman, M.D.
The American Journal of Psychiatry. 2004 August ; 8(161):1324-1333
PDFPDF
Reviews and Overviews | August 01, 2004
Physical Health Monitoring of Patients With Schizophrenia
Stephen R. Marder, M.D.; Susan M. Essock, Ph.D.; Alexander L. Miller, M.D.; Robert W. Buchanan, M.D.; Daniel E. Casey, M.D.; John M. Davis, M.D.; John M. Kane, M.D.; Jeffrey A. Lieberman, M.D.; Nina R. Schooler, Ph.D.; Nancy Covell, Ph.D.; Scott Stroup, M.D., M.P.H.; Ellen M. Weissman, M.D., M.P.H.; Donna A. Wirshing, M.D.; Catherine S. Hall, Pharm.D.; Leonard Pogach, M.D.; Xavier Pi-Sunyer, M.D., M.P.H.; J. Thomas Bigger, Jr., M.D.; Alan Friedman, M.D.; David Kleinberg, M.D.; Steven J. Yevich, M.D., M.P.H.; Bonnie Davis, M.D.; Steven Shon, M.D.
The American Journal of Psychiatry. 2004 August ; 8(161):1334-1349
PDFPDF
Brief Report | July 01, 2004
Medical Decision Making in Antipsychotic Drug Choice for Schizophrenia
Johannes Hamann, M.D.; Bernadette Langer, M.D.; Stefan Leucht, M.D.; Raymonde Busch, Dipl.-Math.; Werner Kissling, M.D.
The American Journal of Psychiatry. 2004 July ; 7(161):1301-1304
PDFPDF
Brief Report | July 01, 2004
Basal Ganglia High-Energy Phosphate Metabolism in Neuroleptic-Naive Patients With Schizophrenia: A 31-Phosphorus Magnetic Resonance Spectroscopic Study
B.N. Gangadhar, M.D.; P.N. Jayakumar, M.D.; D.K. Subbakrishna, Ph.D.; N. Janakiramaiah, M.D., Ph.D.; M.S. Keshavan, M.D.
The American Journal of Psychiatry. 2004 July ; 7(161):1304-1306
PDFPDF
Article | June 01, 2004
Placebo-Controlled Evaluation of Four Novel Compounds for the Treatment of Schizophrenia and Schizoaffective Disorder
Herbert Y. Meltzer, M.D.; Lisa Arvanitis, M.D.; Deborah Bauer, M.S.; Werner Rein, M.D.
The American Journal of Psychiatry. 2004 June ; 6(161):975-984
PDFPDF
Article | June 01, 2004
Comparative Effect of Atypical and Conventional Antipsychotic Drugs on Neurocognition in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus Low Doses of Haloperidol
Richard S.E. Keefe, Ph.D.; Larry J. Seidman, Ph.D.; Bruce K. Christensen, Ph.D.; Robert M. Hamer, Ph.D.; Tonmoy Sharma, M.D.; Margriet M. Sitskoorn, Ph.D.; Richard R.J. Lewine, Ph.D.; Deborah A. Yurgelun-Todd, Ph.D.; Ruben C. Gur, Ph.D.; Mauricio Tohen, M.D., Dr.P.H.; Gary D. Tollefson, M.D., Ph.D.; Todd M. Sanger, Ph.D.; Jeffrey A. Lieberman, M.D.
The American Journal of Psychiatry. 2004 June ; 6(161):985-995
PDFPDF
Brief Report | June 01, 2004
Atypical Antipsychotics and Risk of Cerebrovascular Accidents
Nathan Herrmann, M.D., F.R.C.P.C.; Muhammad Mamdani, Pharm.D., M.A., M.P.H.; Krista L. Lanctôt, Ph.D.
The American Journal of Psychiatry. 2004 June ; 6(161):1113-1115
PDFPDF
Article | May 01, 2004
A PET Study of Dopamine D2 and Serotonin 5-HT2 Receptor Occupancy in Patients With Schizophrenia Treated With Therapeutic Doses of Ziprasidone
David Mamo, M.D., M.Sc., F.R.C.P.(C); Shitij Kapur, M.D., Ph.D., F.R.C.P.(C); C. M. Shammi, M.D., F.R.C.P.(C); George Papatheodorou, M.D., F.R.C.P.(C); Steve Mann, B.A.; François Therrien, Pharm.D.; Gary Remington, M.D., Ph.D., F.R.C.P.(C)
The American Journal of Psychiatry. 2004 May ; 5(161):818-825
PDFPDF
Article | April 01, 2004
Adherence to Treatment With Antipsychotic Medication and Health Care Costs Among Medicaid Beneficiaries With Schizophrenia
Todd P. Gilmer, Ph.D.; Christian R. Dolder, Pharm.D.; Jonathan P. Lacro, Pharm.D.; David P. Folsom, M.D.; Laurie Lindamer, Ph.D.; Piedad Garcia, Ed.D.; Dilip V. Jeste, M.D.
The American Journal of Psychiatry. 2004 April ; 4(161):692-699
PDFPDF
Article | April 01, 2004
Multiple Versus Single Antipsychotic Agents for Hospitalized Psychiatric Patients: Case-Control Study of Risks Versus Benefits
Franca Centorrino, M.D.; Jessica L. Goren, Pharm.D.; John Hennen, Ph.D.; Paola Salvatore, M.D.; James P. Kelleher, M.D.; Ross J. Baldessarini, M.D.
The American Journal of Psychiatry. 2004 April ; 4(161):700-706
PDFPDF
Reviews and Overviews | March 01, 2004
Lower Risk for Tardive Dyskinesia Associated With Second-Generation Antipsychotics: A Systematic Review of 1-Year Studies
Christoph U. Correll, M.D.; Stefan Leucht, M.D.; John M. Kane, M.D.
The American Journal of Psychiatry. 2004 March ; 3(161):414-425
PDFPDF
Brief Report | February 01, 2004
Do Clozapine and Risperidone Affect Social Competence and Problem Solving?
Alan S. Bellack, Ph.D.; Nina R. Schooler, Ph.D.; Stephen R. Marder, M.D.; John M. Kane, M.D.; Clayton H. Brown, Ph.D.; Ye Yang, M.S.
The American Journal of Psychiatry. 2004 February ; 2(161):364-367
PDFPDF
Brief Report | January 01, 2004
Prevalence of Neuroleptic-Induced Movement Disorders in Chronic Schizophrenia Inpatients
Sven Janno, M.D.; Matti Holi, M.D., Ph.D.; Katinka Tuisku, M.D., Ph.D.; Kristian Wahlbeck, M.D., Ph.D.
The American Journal of Psychiatry. 2004 January ; 1(161):160-163
PDFPDF
Brief Report | January 01, 2004
Double-Blind Comparison of the Continued Use of Antipsychotic Treatment Versus Its Discontinuation in Remitted Manic Patients
Carlos A. Zarate, Jr., M.D.; Mauricio Tohen, M.D., Ph.D.
The American Journal of Psychiatry. 2004 January ; 1(161):169-171
PDFPDF
Article | December 01, 2003
Smaller Anterior Hippocampal Formation Volume in Antipsychotic-Naive Patients With First-Episode Schizophrenia
Philip R. Szeszko, Ph.D.; Ethan Goldberg, B.A.; Handan Gunduz-Bruce, M.D.; Manzar Ashtari, Ph.D.; Delbert Robinson, M.D.; Anil K. Malhotra, M.D.; Todd Lencz, Ph.D.; John Bates, Ph.D.; David T. Crandall, Ph.D.; John M. Kane, M.D.; Robert M. Bilder, Ph.D.
The American Journal of Psychiatry. 2003 December ; 12(160):2190-2197
PDFPDF
Brief Report | November 01, 2003
Early Prediction of Antipsychotic Response in Schizophrenia
Christoph U. Correll, M.D.; Anil K. Malhotra, M.D.; Saurabh Kaushik, M.D.; Marjorie McMeniman, Ph.D.; John M. Kane, M.D.
The American Journal of Psychiatry. 2003 November ; 11(160):2063-2065
PDFPDF
Brief Report | November 01, 2003
Olanzapine Effects on Auditory Sensory Gating in Schizophrenia
Celso Arango, M.D.; Ann Summerfelt, B.A.; Robert W. Buchanan, M.D.
The American Journal of Psychiatry. 2003 November ; 11(160):2066-2068
PDFPDF
Copyright ©
American
Psychiatric
Association